Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ULTRAGENYX | 9 | - | +3,57 % | ||
| ROYALTY PHARMA | 6 | - | -0,57 % | ||
| BIONTECH | 5 | 13 | +0,68 % | ||
| PRAXIS PRECISION MEDICINES | 5 | - | -3,05 % | ||
| AMGEN | 3 | 27 | +0,20 % | ||
| PACIRA BIOSCIENCES | 3 | 1 | 0,00 % | ||
| COLLEGIUM PHARMACEUTICAL | 3 | 1 | 0,00 % | ||
| DENALI THERAPEUTICS | 3 | - | +1,24 % | ||
| VIR BIOTECHNOLOGY | 2 | 2 | -3,26 % | ||
| ZEVRA THERAPEUTICS | 2 | 1 | -1,32 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22:06 | Alkermes plc: Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference | 6 | Business Wire | Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 44th Annual J.P. Morgan Healthcare Conference. The... ► Artikel lesen | |
| 22:02 | Grabar Law Office: Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement | 53 | Newsfile | Philadelphia, Pennsylvania--(Newsfile Corp. - December 30, 2025) - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) The investigation... ► Artikel lesen | |
| 19:26 | Jefferies Maintains Buy on Sanofi (SNY) Despite Regulatory Overhang | 8 | Insider Monkey | ||
| 18:48 | Ultragenyx recovers some losses as Jefferies sees potential 2026 rebound | 2 | Seeking Alpha | ||
| 18:34 | BMY vs AMGN: Which Biotech Stock Is More Resilient Now? | 5 | Zacks | ||
| 17:18 | DOMA Perpetual Capital to offer nominees for Pacira BioSciences board | 1 | Seeking Alpha | ||
| 17:06 | DOMA to nominate three directors to Pacira board, urges company sale | 1 | Investing.com | ||
| 17:06 | Denali Therapeutics stock holds Buy rating at Jefferies on FDA approval confidence | 3 | Investing.com | ||
| 16:58 | DOMA fordert Verkauf von Pacira und nominiert drei Kandidaten für den Verwaltungsrat | 2 | Investing.com Deutsch | ||
| 16:58 | Jefferies bestätigt Kaufempfehlung für Denali Therapeutics bei hoher Zuversicht für FDA-Zulassung | 5 | Investing.com Deutsch | ||
| 16:38 | Eilmeldung am Abend: BIONTECH SE ADR zeigt unerwartige Stärke | 29 | Maximilian Berger | ||
| 16:34 | Can Amgen's MariTide Take on Leaders in the Obesity Space? | 10 | Zacks | ||
| 16:30 | Biontech-Aktie entwickelt frische Spannung: Experten sehen mögliches Momentum - BREAKING NEWS! | Hebelschein-Spekulant | |||
| 15:58 | Ultragenyx, Mereo's brittle bone drug flames out in trials | 2 | pharmaphorum | ||
| 15:54 | Ultragenyx Bone Drug Stumbles In Phase 3, But Key Catalysts Remain | 5 | Benzinga.com | ||
| 15:34 | Sanofi-Ausblick trübt sich ein: TD Cowen bestätigt "Halten"-Rating nach regulatorischem Rückschlag | 9 | Investing.com Deutsch | ||
| 15:30 | Sanofi stock outlook dims as TD Cowen reiterates Hold rating | 5 | Investing.com | ||
| 15:22 | Truist Securities bestätigt Kaufempfehlung für Praxis Precision Medicines nach FDA-Meilenstein | 4 | Investing.com Deutsch | ||
| 15:18 | Truist Securities reiterates Buy rating on Praxis Precision Medicines stock | 3 | Investing.com | ||
| 14:58 | Genmab vollzieht Merus-Übernahme und leitet Delisting ein | 3 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .